PMA device
Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
Euclid Vision Corporation · Lens, Contact, Orthokeratology, Overnight (NUU, Class III) · First FDA decision Mar 30, 2021, newest Mar 30, 2021Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
61
Naming "Orthokeratology"
MAUDE reports
12
Brand "Orthokeratology", since 2015
PubMed studies
1,374
Mentioning "Orthokeratology"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P040029-S017 · Decided Mar 30, 2021 · 172 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Orthokeratology", any status and sponsor, newest update first.
- Euclid Phoenix Lens Design Trial 2Completed
Euclid Systems CorporationNot on our public-company list
NCT06392607 · 89 participants · Start May 28, 2024 · Primary completion Sep 8, 2025
Device: Euclid orthokeratology (standard coating); Euclid orthokeratology (enhanced coating) · For: Myopia; Cornea
Sites: Edina, Minnesota; Sartell, Minnesota; North Brunswick, New Jersey · 5 sites in all
- Euclid Phoenix Lens Design TrialCompleted
Euclid Systems CorporationNot on our public-company list
NCT06389916 · 39 participants · Start Nov 1, 2023 · Primary completion May 9, 2024
Device: Euclid orthokeratology MAX (current design); Euclid orthokeratology MAX Phoenix (new design) · For: Myopia; Cornea
Sites: Costa Mesa, California; Saint Johns, Florida; Edina, Minnesota · 5 sites in all
CooperVision International Limited (CVIL)Not on our public-company list
NCT07751172 · 70 participants (planned) · Start Aug 14, 2026 · Primary completion Dec 2026
Device: Lens A (paflufocon D) · For: Myopia; Astigmatism
Sites: Pleasanton, California; Bellaire, Texas; Madrid, Spain
58 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Orthokeratology", and for the whole product code for context.
This brand
12 reports: 2 malfunction, 10 injury, 0 death
Whole product code NUU
40 reports: 3 malfunction, 37 injury, 0 death
Newest reports for this brand
3014175039-2026-00003 · Received Aug 10, 2026 · Event dated Jul 9, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Keratitis
3014175039-2026-00002 · Received May 7, 2026 · Event dated Apr 24, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Keratitis
3014175039-2026-00001 · Received Apr 2, 2026 · Event dated Jan 30, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Keratitis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Orthokeratology"[tiab]. The summary above synthesizes these.
- Overnight orthokeratology.
Bullimore MA, Johnson LA · Cont Lens Anterior Eye · 2020Review
- Myopia and orthokeratology for myopia control.
Cho P, Tan Q · Clin Exp Optom · 2019Review
- [Orthokeratology].
Avetisov SE, Mamikonian VR · Vestn Oftalmol · 1983Review
- Optical interventions for myopia control.
Logan NS, Bullimore MA · Eye (Lond) · 2024Review
- Orthokeratology.
Ziff SL · J Am Optom Assoc · 1976
- Orthokeratology. II.
Ziff SL · J Am Optom Assoc · 1968
- Orthokeratology. 1.
Ziff SL · J Am Optom Assoc · 1968
- Overnight orthokeratology.
Nichols JJ, Marsich MM, Nguyen M, et al. · Optom Vis Sci · 2000Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis.
Tsai HR, Wang JH, Huang HK, et al. · J Formos Med Assoc · 2022Systematic Review, Network Meta-Analysis
- Orthokeratology-related Acanthamoeba keratitis in a 13-year-old.
Singh V, Lallu J, Ramachandran N, et al. · Clin Exp Optom · 2023
- Overnight orthokeratology.
Garber JM · Optom Vis Sci · 2001Comment, Letter
- The myopia movement.
Kang P, Lam M, Doig G, et al. · Clin Exp Optom · 2020Editorial
Other devices of this type
Also filed under product code NUU.
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) ContactEuclid Vision Corporation · PMA 2026
- Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping TreatmentBausch & Lomb · PMA 2025
- Menicon Z Night (tisilfocon A) Contact Lenses for Overnight WearMenicon Co, Ltd. · PMA 2022
- Paragon Z CRT (tisilfocon A) and Paragon Z CRT Dual Axis (tisilfocon A) Rigid Gas Permeable Contact lenses in blue tintCooperVision, Inc. · PMA 2019
- Jsz Orthokeratology (Oprifocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2016
- DilightTM (roflufocon E) Overnight Orthokeratology Contact LensTianjin MasterVision Technology Co., Ltd. · PMA 2026
- Optimum Infinite (tisilfocon A) Orthokeratology Lenses IIContamac, Ltd. · PMA 2026
- ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia ManagementMenicon Co, Ltd. · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.